Gap junction protein inhibitor, Gap 27, Purity ≥98%

Synonym: 198284-64-9; Gap-27; Gap27; (2S,3S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S,3R)-2-[[(2S)-6-Amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoyl]amino]-4-carboxybutanoyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-3-methylpentanoyl]amino]-3-methylpentanoic acid

MDL: MFCD11045577
CAS Number: 198284-64-9
Compound CID: 9920128

Product Size

5 mg; 10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Gap 27 is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting gap junction protein.

Molecular Weight

1304.55

Molecular Formula

C₆₀H₁₀₁N₁₅O₁₇

Form

Lyophilized powder

Purity

≥98%

Titer

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects

Applications

Gap 27 is a cytoskeletal signaling inhibitor that can be used for its potential impact on diseases related to gap junction dysfunction, including cancer and cardiovascular disorders.